Observational Research & Registries

Real-world research determines real-world impact

Gathering evidence of your product’s value doesn't end at market approval. Quintiles' leading expertise in observational research helps you clearly demonstrate how treatments perform in the real world with patients receiving standard care.

banner_woman doctor smiling

195 patient registries and observational studies since 2003

Quintiles has developed 195 patient registries and observational studies since 2003.

Proving value beyond market approval

Your stakeholders, including regulators, payers, patients and providers, are looking beyond market approval; they want to see that your product can deliver proven, tangible value. Through observational research in real-world settings, you can develop a robust story of safety, effectiveness and quality that clearly details your product’s performance, including how it’s helping those who need it most.

Observational research and registries

The Right Approach for the Right Question®: Generate the evidence you need to demonstrate the value stakeholders demand in the real world

Quintiles brings leading expertise gained from more than 175 observational and real-world research studies, including:

  • Patient registries. Collect valuable data about how products perform in real-world conditions.
  • Patient-reported outcomes. Support treatment benefits and claims in approved product labeling.
  • Safety surveillance/REMS. Track long-term safety outcomes, mitigate risk and monitor off-label use.
  • Effectiveness/CER. Demonstrate effectiveness or comparative effectiveness in different populations.
  • Health outcomes/Health economics. Support formulary approval or secure favorable reimbursement.
  • Retrospective healthcare data. Access electronic healthcare records through our databases and networks.

The power of possibilities

Realizing maximum success for your product doesn’t end at market approval. Quintiles will work with you to answer every question completely, accurately and efficiently, from every stakeholder about your product’s real-world impact.

Related services

Quintiles has provided clinical services to more than 475 real-world and late phase programs since 2011.
Quintiles has access to >61M patient lives via EHRs since 2004.
Quintiles Expert

Global Chief of Scientific Affairs and Senior Vice President, Real-World & Late Phase Research

Recent thinking: Using registries to support HTA submissions in Japan

Vice President, Global Head of Risk Management, Real-World & Late Phase Research

Recent thinking: The Friday Podcast: Moving toward patient centricity